Skip Navigation Links
Centers for Disease Control and Prevention
CDC Home Search Health Topics A-Z




Home | Contact Us
 Health and Human Services Logo



Animated FirstGov Logo - Click to enter FirstGov


Hantavirus Pulmonary Syndrome (Hantavirus Disease) (HPS)

Contents
Home - National Notifiable Diseases Surveillance System
Overview
Introduction
List of Infectious Nationally Notifiable Condtions
List of Non-Infectious Nationally Notifiable Conditions
Alphabetical List of Case Definitions
Definition of Terms
Related Links
References
  Site Search


2010 Case Definition

CSTE Position Statement Number: 09-ID-17

Clinical description

Hantavirus pulmonary syndrome (HPS), commonly referred to as hantavirus disease, is a febrile illness characterized by bilateral interstitial pulmonary infiltrates and respiratory compromise usually requiring supplemental oxygen and clinically resembling acute respiratory disease syndrome (ARDS). The typical prodrome consists of fever, chills, myalgia, headache, and gastrointestinal symptoms. Typical clinical laboratory findings include hemoconcentration, left shift in the white blood cell count, neutrophilic leukocytosis, thrombocytopenia, and circulating immunoblasts.

Clinical case definition

An illness characterized by one or more of the following clinical features:
  • A febrile illness (i.e., temperature greater than 101.0° F [greater than 38.3° C]) corroborated by bilateral diffuse interstitial edema or a clinical diagnosis of acute respiratory distress syndrome (ARDS) or radiographic evidence of noncardiogenic pulmonary edema, or unexplained respiratory illness resulting in death, and occurring in a previously healthy person
  • An unexplained respiratory illness resulting in death, with an autopsy examination demonstrating noncardiogenic pulmonary edema without an identifiable cause

Laboratory criteria for diagnosis

  • Detection of hantavirus-specific immunoglobulin M or rising titers of hantavirus-specific immunoglobulin G, or
  • Detection of hantavirus-specific ribonucleic acid sequence by polymerase chain reaction in clinical specimens, or
  • Detection of hantavirus antigen by immunohistochemistry

Case classification

  • Confirmed: a clinically compatible case that is laboratory confirmed

Comment

Laboratory testing should be performed or confirmed at a reference laboratory. Because the clinical illness is nonspecific and ARDS is common, a screening case definition can be used to determine which patients to test. In general, a predisposing medical condition (e.g., chronic pulmonary disease, malignancy, trauma, burn, and surgery) is a more likely cause of ARDS than HPS, and patients who have these underlying conditions and ARDS need not be tested for hantavirus.

See also:

Printable Version

 


 



Privacy Policy | Accessibility

Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last updated November 17, 2011

United States Department of Health and Human Services
Centers for Disease Control and Prevention